Introduction of Brexucabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Lifileucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of CD24Fc Immunomodulator into Central Vein, Percutaneous Approach, New Technology Group 6 Code History

Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9 Code History

Introduction of Idecabtagene Vicleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Tisagenlecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Other New Technology Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6 Code History

Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5 Code History

Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7 Code History